JAK inhibitors in dermatology: The promise of a new drug class. - Abstract - Europe PMC
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
After 25 years of drug development, do we know JAK? | RMD Open
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
JAK Inhibitor 瑞石生物医药有限公司
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
User's guide to JAK inhibitors in inflammatory bowel disease - ScienceDirect
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
Overview of the Jak inhibitors as targeted biologic therapies in... | Download Scientific Diagram
JAK阻害 | JAK Inhibition
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
Current and future status of JAK inhibitors - The Lancet
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Selective JAK inhibitors | Future Medicinal Chemistry
